Culture and Real-time Polymerase Chain reaction sensitivity in the diagnosis of invasive meningococcal disease: Does culture miss less severe cases?
Adolescent
Bacterial Load
/ methods
Cell Culture Techniques
/ statistics & numerical data
Child
Child, Preschool
DNA, Bacterial
/ isolation & purification
False Negative Reactions
Female
Humans
Infant
Infant, Newborn
Male
Meningitis, Meningococcal
/ diagnosis
Neisseria meningitidis
/ genetics
Real-Time Polymerase Chain Reaction
/ statistics & numerical data
Retrospective Studies
Sensitivity and Specificity
Sepsis
/ diagnosis
Severity of Illness Index
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
10
08
2018
accepted:
12
02
2019
entrez:
14
3
2019
pubmed:
14
3
2019
medline:
28
11
2019
Statut:
epublish
Résumé
Invasive meningococcal disease (IMD) is a highly lethal disease. Diagnosis is commonly performed by culture or Realtime-PCR (qPCR). Our aim was to evaluate, retrospectively, whether culture positivity correlates with higher bacterial load and fatal outcome. Our secondary aim was to compare culture and qPCR sensitivity. The National Register for Molecular Surveillance was used as data source. Cycle threshold (CT), known to be inversely correlated with bacterial load, was used to compare bacterial load in different samples. Three-hundred-thirteen patients were found positive for Neisseria meningitidis by qPCR, or culture, or both; 41 died (case fatality rate 13.1%); 128/143 (89.5%) blood samples and 138/144 (95.8%) CSF were positive by qPCR, 37/143 (25.9%) blood samples and 45/144 (31.2%) CSF were also positive in culture. qPCR was 3.5 times (blood) or 3.1 times (CSF) more sensitive than culture in achieving a laboratory diagnosis of IMD (OR 24.4; 95% CI 12.2-49.8; p < .10-4; Cohen's κ 0.08 for blood and OR 49.0; 95% CI 19.1-133.4; p<10-4; Cohen's κ 0.02; for CSF). Positivity of culture did not correlate with higher bacterial loads in blood (mean CT 27.7±5.71, and CT 28.1±6.03, p = 0.739 respectively in culture positive or negative samples) or in CSF (mean CT 23.1±4.9 and 24.7±5.4 respectively in positive or negative CSF samples, p = 0.11).CT values in blood from patients who died were significantly lower than in patients who survived (respectively mean 18.0, range 14-23 and mean 29.6, range 16-39; p<10-17). No deaths occurred in patients with CT in blood over 23. Positive blood cultures were found in 10/25 (40%) patients who died and in 32/163 (19.6%) patients who survived, p = 0.036, OR 2.73; 95% CL 1.025-7.215), however 60% of deaths would have remained undiagnosed with the use of culture only. In conclusion our study demonstrated that qPCR is significantly (at least 3 times) more sensitive than culture in the laboratory confirmation of IMD. The study also demonstrated that culture negativity is not associated with lower bacterial loads and with less severe cases. On the other side, in patients with sepsis, qPCR can predict fatal outcome since higher bacterial load, evaluated by qPCR, appears strictly associated with most severe cases and fatal outcome. The study also showed that molecular techniques such as qPCR can provide a valuable addition to the proportion of diagnosed and serotyped cases of IMD.
Sections du résumé
BACKGROUND
Invasive meningococcal disease (IMD) is a highly lethal disease. Diagnosis is commonly performed by culture or Realtime-PCR (qPCR).
AIMS
Our aim was to evaluate, retrospectively, whether culture positivity correlates with higher bacterial load and fatal outcome. Our secondary aim was to compare culture and qPCR sensitivity.
METHODS
The National Register for Molecular Surveillance was used as data source. Cycle threshold (CT), known to be inversely correlated with bacterial load, was used to compare bacterial load in different samples.
RESULTS
Three-hundred-thirteen patients were found positive for Neisseria meningitidis by qPCR, or culture, or both; 41 died (case fatality rate 13.1%); 128/143 (89.5%) blood samples and 138/144 (95.8%) CSF were positive by qPCR, 37/143 (25.9%) blood samples and 45/144 (31.2%) CSF were also positive in culture. qPCR was 3.5 times (blood) or 3.1 times (CSF) more sensitive than culture in achieving a laboratory diagnosis of IMD (OR 24.4; 95% CI 12.2-49.8; p < .10-4; Cohen's κ 0.08 for blood and OR 49.0; 95% CI 19.1-133.4; p<10-4; Cohen's κ 0.02; for CSF). Positivity of culture did not correlate with higher bacterial loads in blood (mean CT 27.7±5.71, and CT 28.1±6.03, p = 0.739 respectively in culture positive or negative samples) or in CSF (mean CT 23.1±4.9 and 24.7±5.4 respectively in positive or negative CSF samples, p = 0.11).CT values in blood from patients who died were significantly lower than in patients who survived (respectively mean 18.0, range 14-23 and mean 29.6, range 16-39; p<10-17). No deaths occurred in patients with CT in blood over 23. Positive blood cultures were found in 10/25 (40%) patients who died and in 32/163 (19.6%) patients who survived, p = 0.036, OR 2.73; 95% CL 1.025-7.215), however 60% of deaths would have remained undiagnosed with the use of culture only.
CONCLUSIONS
In conclusion our study demonstrated that qPCR is significantly (at least 3 times) more sensitive than culture in the laboratory confirmation of IMD. The study also demonstrated that culture negativity is not associated with lower bacterial loads and with less severe cases. On the other side, in patients with sepsis, qPCR can predict fatal outcome since higher bacterial load, evaluated by qPCR, appears strictly associated with most severe cases and fatal outcome. The study also showed that molecular techniques such as qPCR can provide a valuable addition to the proportion of diagnosed and serotyped cases of IMD.
Identifiants
pubmed: 30865671
doi: 10.1371/journal.pone.0212922
pii: PONE-D-18-23624
pmc: PMC6415896
doi:
Substances chimiques
DNA, Bacterial
0
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0212922Déclaration de conflit d'intérêts
SG received a scholarship from GSK for meningococcal epidemiology; GSK did not participate in study design, data analysis, manuscript writing and in any other aspects related to the present work. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The authors have no other conflict of interest.
Références
Int J Microbiol. 2016;2016:4197187
pubmed: 27563310
Mol Diagn Ther. 2011 Apr 1;15(2):109-13
pubmed: 21452905
Clin Infect Dis. 2009 Mar 1;48(5):587-94
pubmed: 19191644
Commun Dis Intell Q Rep. 2012 Mar 31;36(1):1-69
pubmed: 23153082
Clin Infect Dis. 2010 Nov 1;51(9):1042-9
pubmed: 20883110
N Engl J Med. 2006 Oct 19;355(16):1699-713
pubmed: 17050894
N Engl J Med. 2001 May 3;344(18):1378-88
pubmed: 11333996
PLoS One. 2015 Mar 23;10(3):e0120757
pubmed: 25798599
Am J Trop Med Hyg. 2009 Sep;81(3):475-83
pubmed: 19706918
Vaccine. 2014 Feb 26;32(10):1187-91
pubmed: 24120548
Clin Ther. 2009 Jun;31(6):1266-73
pubmed: 19695393
Pediatr Crit Care Med. 2005 May;6(3 Suppl):S14-8
pubmed: 15857548
J Infect. 2016 Nov;73(5):427-436
pubmed: 27475788
Emerg Infect Dis. 2016 Mar;22(3):469-75
pubmed: 26890305
Arch Dis Child. 2002 Jan;86(1):44-6
pubmed: 11806883
Iran J Microbiol. 2010 Jun;2(2):73-9
pubmed: 22347552
FEMS Immunol Med Microbiol. 2003 Oct 24;39(1):31-6
pubmed: 14556993
Pediatrics. 2001 Nov;108(5):1169-74
pubmed: 11694698
J Infect. 2013 Nov;67(5):385-90
pubmed: 23796865
PLoS One. 2011 May 05;6(5):e19361
pubmed: 21573213
Pediatr Infect Dis J. 2007 May;26(5):416-22
pubmed: 17468652
PLoS One. 2010 Feb 19;5(2):e9282
pubmed: 20174571